ANALYSIS: Strong Growth Data: No Soft Landing for Inflation

For those who follow closely the Atlanta Fed’s invaluable GDPNow estimate, today’s 4.9 percent real annual growth rate for the third quarter w...

For those who follow closely the Atlanta Fed’s invaluable GDPNow estimate, today’s 4.9 percent real annual growth rate for the third quarter was a slightly negative surprise, as the mavens in Atlanta expected the number to be north of 5 percent. But for virtually everyone else who has been dining on a steady diet of “soft landing” rhetoric from Fed watchers, it was a major upside surprise.

The bottom line is that there are two parts to the story, one short run and transitory and the other...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

AllSidesNow /  🏆 572. in US

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Battery firm LG Energy Solution warns of slower growth after strong Q3Battery firm LG Energy Solution warns of slower growth after strong Q3
Read more »

Silver Price Analysis: XAG/USD retraces amidst sour market mood, strong US DollarSilver prices (XAG/USD) dropped in the mid-North American session on Wednesday as market sentiment turned negative, which usually underpins the grey m
Read more »

Strong US economic growth for last quarter likely reflected consumers' resistance to Fed rate hikesThe government is expected to report stellar growth for the U.S. economy during the July-September quarter, highlighting the durability of consumer and business spending despite the Federal Reserve’s efforts to cool the expansion with high interest rates.
Read more »

NOK to struggle in an environment of weakening growth, tight monetary conditions and strong USDEUR/NOK breached the 11.80 mark despite commodity prices rising over the past month, highlighting the importance of the global backdrop. Economists at
Read more »

Merck results beat expectations on strong Keytruda, Gardasil and Covid drug growthMerck’s revenue and earnings beat expectations, and it hiked its sales forecast while lowering its profit outlook.
Read more »

Merck results beat expectations on strong Keytruda sales, surprise Covid drug growthMerck's revenue and earnings beat expectations, and it hiked its sales forecast while lowering its profit outlook.
Read more »